Novo Nordisk, Eli Lilly and Pfizer are developing weight loss pills. Meanwhile, digital health funding shows ‘measured momentum’ this year, a report…
Good afternoon! Several drugmakers are hurrying to capitalize on one of the next major innovations coming to the booming weight loss drug market: effective, convenient and potentially affordable obesity pills.Most of the weight loss and diabetes drugs available now are weekly injections, such as Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Zepbound and Mounjaro. They are among medications called GLP-1 agonists, which have skyrocketed in popularity over the last year.
The company at the time said it plans to file for Food and Drug Administration approval in 2023. Novo Nordisk has not indicated whether it has.on another experimental weight loss pill called amycretin, which helped people lose 13.1% of their weight after 12 weeks in an early-stage trial. Results from a mid-stage trial are not expected until 2026.
Rock Health said that Series A activity was especially strong in the first half of this year, though Seed rounds and Series B checks were also popular. Seed, Series A and Series B funding made up nearly 85% of all labeled raises for the period, the report said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »
‘Healthy’ kids’ foods that are not healthyOne in five kids and adolescents in the U.S. is obese and it’s considered a serious public health problem.
Read more »
Healthy Leaders Build Healthy CompaniesI am a doctor uncovering the secrets of workplace wellness and human performance. As an experienced management consultant and the Physician Lead of Advisory Services at Cleveland Clinic Canada, I advise global C-suite executives on people strategies at the intersection of health and business.
Read more »
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trialBrain implant company Paradromics is preparing for human trials, while President Biden’s poor debate performance affected health-care stocks.
Read more »
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trialBrain implant company Paradromics is preparing for human trials, while President Biden’s poor debate performance affected health-care stocks.
Read more »